A Phase I/II Clinical Trial of "Off-the-shelf" NK Cell Administration in Combination With Allogeneic SCT to Decrease Disease Relapse in Patients With High-risk Myeloid Malignancies Undergoing Matched Related, Matched Unrelated, One Antigen Mismatched Unrelated, or Haploidentical Stem-cell Transplantation
Arms / Cohorts
Experimental:Cyclophosphamide
Accepting patients
Experimental:Mesna
Accepting patients
Experimental:Filgrastim
Accepting patients
Experimental:Melphalan
Accepting patients
Experimental:Fludarabine phosphate
Accepting patients
Experimental:Tacrolimus
Accepting patients
Experimental:Mycophenolate mofetil
Accepting patients
Experimental:Total Body Irradiation
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.